Why the study?
Information was limited regarding the mid- and long-term follow-up of patients undergoing CABG with versus without left main coronary artery disease in the authors' setting.
Does the presence of left main coronary artery disease increase long-term mortality, AMI, or stroke in patients undergoing CABG?
Does the presence of left main coronary artery disease increase long-term mortality, AMI, or stroke in patients undergoing CABG?
The presence of left main coronary artery disease does not adversely affect long-term survival or freedom from myocardial infarction and stroke in patients undergoing coronary artery bypass grafting.
LMCA disease does not appear to worsen long-term CABG outcomes; supports equivalent prognosis but leaves open confirmation in randomized trials.
Background: Coronary artery bypass grafting (CABG) has modified the natural evolution of patients with left main coronary artery (LMCA) disease. There is little information in our setting regarding the mid- and long-term follow-up of operated patients. Objective: The aim of this study was to evaluate the implication of LMCA disease in the long-term evolution of patients operated on with CABG, and to assess the mortality and incidence of myocardial infarction (AMI) and/or stroke. Results: Follow-up was completed in 438 patients (95.6%) with a median of 58 months [interquartile range (IQR) 35-88 months]. Actuarial survival at 10 years was 91.8% for the entire population, with no significant differences between the LMCA group (91.57%) vs. the non-LMCA group (91.86%), HR 1,008 95% CI 0.38-2.65, p=0.98. In multivariate analysis, preoperative left ventricular ejection fraction (HR = 0.95; 95% CI 0.93-0.97; p < 0.001), age (HR 1.1, 95% CI 1.04-1.13, p<0.001) and non-elective priority of surgery (HR=3.71; 95% CI 1.3-10.35; p=0.01) were independent predictors of long-term mortality. AMI-free survival was 96.8% (LMCA 94% vs. non-LMCA 97.4%, p=0.8) and freedom from stroke was 98% (LMCA 97.8% vs. non-LMCA 98.1 %, p=0.8). Conclusion: In patients undergoing CABG, the presence of LMCA disease did not increase the rate of hard events (death, AMI, and stroke) at the long-term follow-up. The results obtained in this series of patients are similar to those published in the international literature used to develop myocardial revascularization guidelines
No takes yet. Share an insight, caveat, or question.
Vaccarino et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: